Citations (104)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (18)
Hollie Porras, Elizabeth Johnson, Mariya Kotova, James Chenoweth & Daniel Colby. (2023) Buprenorphine Inductions via Transdermal Patches for Opioid Use Disorder in the Inpatient Setting. Journal of Pain & Palliative Care Pharmacotherapy 37:3, pages 251-256.
Read now
Read now
Robert Nunn, Anne Sylvestre, Kelly Sequeira & Rosa Maria Tanzini. (2023) Buprenorphine/naloxone micro-induction in a tertiary care hospital: a retrospective cohort analysis. Journal of Addictive Diseases 0:0, pages 1-7.
Read now
Read now
Barbara Andraka-Christou, Matthew Douglas Evans, Beth Tranen & Natasha S. Mendoza. (2023) Legal Limitations Associated with Microdosing Buprenorphine. Substance Use & Misuse 58:7, pages 956-959.
Read now
Read now
Sivabalaji Kaliamurthy, Oluwole Jegede & Gretchen Hermes. (2023) Community based buprenorphine micro-induction in the context of methadone maintenance treatment and fentanyl – Case report. Journal of Addictive Diseases 41:2, pages 175-180.
Read now
Read now
Pouya Azar, Nickie Mathew, Daljeet Mahal, James S.H. Wong, Jean N. Westenberg, Christian G. Schütz & Mark K. Greenwald. (2023) Developing A Rapid Transfer from Opioid Full Agonist to Buprenorphine: “Ultrarapid Micro-Dosing” Proof of Concept. Journal of Psychoactive Drugs 55:1, pages 94-101.
Read now
Read now
Joshua MacAusland-Berg, Amy Wiebe, Radhika Marwah & Katelyn Halpape. (2022) Successful conversion from butorphanol nasal spray to buprenorphine/naloxone using a low-dose regimen to assist with opioid tapering in the setting of chronic pain and migraine management in an older adult patient: A case report. Canadian Journal of Pain 6:1, pages 135-141.
Read now
Read now
Jonna M. Leyrer-Jackson, Amanda M. Acuña & M. Foster Olive. (2022) Current and emerging pharmacotherapies for opioid dependence treatments in adults: a comprehensive update. Expert Opinion on Pharmacotherapy 23:16, pages 1819-1830.
Read now
Read now
Jose Perez Martell, Jaya Sri Konakanchi & Roopa Sethi. (2022) Treating opioid use disorder with rapid micro induction technique of sublingual buprenorphine/naloxone in an outpatient setting—a case report. Journal of Addictive Diseases 40:3, pages 439-443.
Read now
Read now
Chris Schlechter, Rubayet Hossain & Charles L. Emerman. (2022) Safety of induction at standard doses of buprenorphine for inpatients with opioid use disorder. Journal of Addictive Diseases 40:3, pages 299-305.
Read now
Read now
Anthony Spadaro, Abeed Sarker, Whitney Hogg-Bremer, Jennifer S. Love, Nicole O’Donnell, Lewis S. Nelson & Jeanmarie Perrone. (2022) Reddit discussions about buprenorphine associated precipitated withdrawal in the era of fentanyl. Clinical Toxicology 60:6, pages 694-701.
Read now
Read now
Kevin Baumgartner, Ellen Salmo, David Liss, Jason Devgun, Michael Mullins, Bridget Galati, Jeannie Kelly & Evan Schwarz. (2022) Transdermal buprenorphine for in-hospital transition from full agonist opioids to sublingual buprenorphine: a retrospective observational cohort study. Clinical Toxicology 60:6, pages 688-693.
Read now
Read now
Jonathan P. DeWeese, James R. Krenz, Sarah E. Wakeman & Alyssa M. Peckham. (2021) Rapid buprenorphine microdosing for opioid use disorder in a hospitalized patient receiving very high doses of full agonist opioids for acute pain management: Titration, implementation barriers, and strategies to overcomes. Substance Abuse 42:4, pages 506-511.
Read now
Read now
Hance Clarke, Aliza Weinrib, Yuvaraj Kotteeswaran, Joel Katz, Alvis Yu & Robert Tanguay. (2020) Remote buprenorphine-naloxone initiation as an essential service for people with chronic pain and opioid dependence during the COVID-19 pandemic: Case reports, clinical pathways, and implications for the future. Canadian Journal of Pain 4:1, pages 224-235.
Read now
Read now
Gabi Koller, Andreas Schwarzer, Kathrin Halfter & Michael Soyka. (2019) Pain management in opioid maintenance treatment. Expert Opinion on Pharmacotherapy 20:16, pages 1993-2005.
Read now
Read now
Marc Vogel, Patrick Köck, Johannes Strasser, Gerhard Wiesbeck, Marc Walter & Kenneth M. Dürsteler. (2019) Chronic High-Dose Buprenorphine Does Not Block Subjective High from Diacetylmorphine in a Patient in Heroin-Assisted Treatment. Journal of Psychoactive Drugs 51:4, pages 377-382.
Read now
Read now
Raman Sandhu, Rebecca Zivanovic, Sukhpreet Klaire, Mohammadali Nikoo, Jennifer Rozylo & Pouya Azar. (2019) Buprenorphine/naloxone induction for treatment of acute on chronic pain using a micro-dosing regimen: A case report. Canadian Journal of Pain 3:1, pages 79-84.
Read now
Read now
Kent C. Grimes & Fabrizzio Delgado. Inpatient transition of methadone to Suboxone via rapid micro-induction in sepsis: a case report. Journal of Substance Use 0:0, pages 1-3.
Read now
Read now
Alia Bodnar, Christine Diffenderffer, Lindsay A. Jablonski, Eric Bai & Rosalyn W. Stewart. Use of intravenous buprenorphine microdosing to initiate medication for opioid use disorder in a patient with co-occurring pain: case report. Journal of Addictive Diseases 0:0, pages 1-5.
Read now
Read now
Articles from other publishers (86)
Andreas Pilarinos, Brittany Bingham, Yandi Kwa, Ronald Joe, Cameron Grant, Danya Fast, Jane A. Buxton & Kora DeBeck. (2023) Interest in using buprenorphine-naloxone among a prospective cohort of street-involved young people in Vancouver, Canada. Journal of Substance Use and Addiction Treatment 148, pages 209005.
Crossref
Crossref
Carolyn Anderson, Rachel Cooley & Dustin Patil. (2023) Transitioning From High-dose Methadone to Buprenorphine Using a Microdosing Approach: Unique Considerations at ASAM Level 3 Facilities. Journal of Addiction Medicine 17:2, pages 241-244.
Crossref
Crossref
Pouya Azar, James S.H. Wong, Nickie Mathew, Marc Vogel, Jeanmarie Perrone, Andrew A. Herring, Reinhard M. Krausz, Julio S.G. Montaner, Mark K. Greenwald & Anil R. Maharaj. (2023) 48-hour Induction of Transdermal Buprenorphine to Sublingual Buprenorphine/Naloxone: The IPPAS Method. Journal of Addiction Medicine 17:2, pages 233-236.
Crossref
Crossref
Nika Sulakvelidze, Clare Ronan, Alyssa F. Peterkin & Zoe M. Weinstein. (2023) Efficacy of Low-Dose Versus Traditional Buprenorphine Induction in the Hospital: A Quantitative and Qualitative Study. American Journal of Therapeutics 30:1, pages e1-e9.
Crossref
Crossref
Monika Hardy, Samantha Grable, Rachel Otley & Michelle Pershing. (2023) Survey of Buprenorphine Low-dose Regimens Used by Healthcare Institutions. Journal of Addiction Medicine Publish Ahead of Print.
Crossref
Crossref
Marnie Noel, Elizabeth Abbs, Leslie Suen, Lysa Samuel, Sarah Dobbins, Michelle Geier & Christine S. Soran. (2023) The Howard Street Method: A Community Pharmacy-Led Low Dose Overlap Buprenorphine Initiation Protocol for Individuals Using Fentanyl. Journal of Addiction Medicine Publish Ahead of Print.
Crossref
Crossref
Marc Vogel, Kenneth M. Dürsteler & Kenneth M. Dürsteler. (2023) Buprenorphine Induction: Just a Piece of the Puzzle. Journal of Addiction Medicine Publish Ahead of Print.
Crossref
Crossref
Nikhil Seval, Johnathan Nunez, Prerana Roth, Meredith Schade, Michelle Strong, Cynthia A. Frank, Alain H. Litwin, Frances R. Levin, Kathleen T. Brady, Edward V. Nunes & Sandra A. Springer. (2023) Inpatient Low-dose Transitions From Full Agonist Opioids Including Methadone Onto Long-acting Depot Buprenorphine: Case Series From a Multicenter Clinical Trial. Journal of Addiction Medicine Publish Ahead of Print.
Crossref
Crossref
Rebecca Coish & Janine Hardial. (2023) Successful Buprenorphine/Naloxone Low-dose Induction in Pregnancy: A Case Report. Journal of Addiction Medicine 17:1, pages 114-116.
Crossref
Crossref
Elizabeth McCord, Charlotte Van Hale & Yi-Lang Tang. 2023. Substance Use and Addiction Research. Substance Use and Addiction Research
349
367
.
Kishan V. Patel, Sidharth Sahni & Lanvin F. Taylor. (2022) Successful buprenorphine transition while overlapping with a full opioid agonist to treat chronic pain: a case report. Journal of Osteopathic Medicine 123:1, pages 1-5.
Crossref
Crossref
Zoe A. Karavolis & Payel J. Roy. (2022) Adapting low-dose buprenorphine induction to meet patient needs: A pilot study. Drug and Alcohol Dependence Reports 5, pages 100104.
Crossref
Crossref
Mark K. Greenwald, Andrew A. Herring, Jeanmarie Perrone, Lewis S. Nelson & Pouya Azar. (2022) A Neuropharmacological Model to Explain Buprenorphine Induction Challenges. Annals of Emergency Medicine 80:6, pages 509-524.
Crossref
Crossref
Laura Szczesniak & Ross Sullivan. (2022) Microdose Induction of Buprenorphine in a Patient Using Tianeptine. Journal of Addiction Medicine 16:6, pages 736-738.
Crossref
Crossref
Adams K. K.Miech E. J.Sobieraj D. M.. (2022) Factors that distinguish opioid withdrawal during induction with buprenorphine microdosing: a configurational analysis. Addiction Science & Clinical Practice 17:1.
Crossref
Crossref
Lindsay A. Jablonski, Alia R. Bodnar & Rosalyn W. Stewart. (2022) Development of an intravenous low-dose buprenorphine initiation protocol. Drug and Alcohol Dependence 237, pages 109541.
Crossref
Crossref
Anthony Spadaro, Brit Long, Alex Koyfman & Jeanmarie Perrone. (2022) Buprenorphine precipitated opioid withdrawal: Prevention and management in the ED setting. The American Journal of Emergency Medicine 58, pages 22-26.
Crossref
Crossref
Shannon Menard & Archana Jhawar. (2022) Outpatient Microdose Induction with Transdermal Buprenorphine: A Case Series. Healthcare 10:7, pages 1307.
Crossref
Crossref
Kimberly L. Sue, Shawn Cohen, Jess Tilley & Avi Yocheved. (2022) A Plea From People Who Use Drugs to Clinicians: New Ways to Initiate Buprenorphine Are Urgently Needed in the Fentanyl Era. Journal of Addiction Medicine 16:4, pages 389-391.
Crossref
Crossref
Elenore P. Bhatraju, Jared W. Klein, Allana N. Hall, David R. Chen, Matthew Iles-Shih, Judith I. Tsui & Joseph O. Merrill. (2022) Low Dose Buprenorphine Induction With Full Agonist Overlap in Hospitalized Patients With Opioid Use Disorder: A Retrospective Cohort Study. Journal of Addiction Medicine 16:4, pages 461-465.
Crossref
Crossref
Shawn M. Cohen, Melissa B. Weimer, Ximena A. Levander, Alyssa M. Peckham, Jeanette M. Tetrault & Kenneth L. Morford. (2022) Low Dose Initiation of Buprenorphine: A Narrative Review and Practical Approach. Journal of Addiction Medicine 16:4, pages 399-406.
Crossref
Crossref
Hazel Brogdon, Kaden L. Facer, Emily J. Cox, Richard H. Carlson & John F. Wurzel. (2022) Rapid Transition to Buprenorphine in a Patient With Methadone-Related QTc Interval Prolongation. Journal of Addiction Medicine 16:4, pages 488-491.
Crossref
Crossref
Gian-Gabriel P. Garcia, Ramin Dehghanpoor, Erin J. Stringfellow, Marichi Gupta, Jillian Rochelle, Elizabeth Mason, Toyya A. Pujol & Mohammad S. Jalali. (2022) Identifying and Characterizing Medical Advice-Seekers on a Social Media Forum for Buprenorphine Use. International Journal of Environmental Research and Public Health 19:10, pages 6281.
Crossref
Crossref
Lauren A. Spreen, Emma N. Dittmar, Kyle C. Quirk & Michael A. Smith. (2022) Buprenorphine initiation strategies for opioid use disorder and pain management: A systematic review. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 42:5, pages 411-427.
Crossref
Crossref
Hanis Mohammad Hazani, Isa Naina Mohamed, Mustapha Muzaimi, Wael Mohamed, Mohamad Fairuz Yahaya, Seong Lin Teoh, Rashidi Mohamed Pakri Mohamed, Mohd Fadzli Mohamad Isa, Sundus Mansoor Abdulrahman, Ravi Ramadah, Mohammad Rahim Kamaluddin & Jaya Kumar. (2022) Goofballing of Opioid and Methamphetamine: The Science Behind the Deadly Cocktail. Frontiers in Pharmacology 13.
Crossref
Crossref
Sarah Leyde, Leslie Suen, Lisa Pratt & Triveni DeFries. (2022) Transition from Oxycodone to Buprenorphine/Naloxone in a Hospitalized Patient with Sickle Cell Disease: A Case Report. Journal of General Internal Medicine 37:5, pages 1281-1285.
Crossref
Crossref
Bridin P Murnion & Apo Demirkol. (2022) Opioid use disorder in anaesthesia and intensive care: Prevention, diagnosis and management. Anaesthesia and Intensive Care 50:1-2, pages 95-107.
Crossref
Crossref
Dana Button, Jennifer Hartley, Jonathan Robbins, Ximena A. Levander, Natashia J. Smith & Honora Englander. (2022) Low-dose Buprenorphine Initiation in Hospitalized Adults With Opioid Use Disorder: A Retrospective Cohort Analysis. Journal of Addiction Medicine 16:2, pages e105-e111.
Crossref
Crossref
Duncan Hill, Victoria Hayes, Apo Demirkol & Nicholas Lintzeris. (2022) Clinical Case Conference: Strategies for Transferring From Methadone to Buprenorphine. Journal of Addiction Medicine 16:2, pages 152-156.
Crossref
Crossref
Daniel Shearer, Samantha Young, Nadia Fairbairn & Rupinder Brar. (2021) Challenges with buprenorphine inductions in the context of the fentanyl overdose crisis: A case series. Drug and Alcohol Review 41:2, pages 444-448.
Crossref
Crossref
Jessica L. Taylor & Jeffrey H. Samet. (2022) Opioid Use Disorder. Annals of Internal Medicine 175:1, pages ITC1-ITC16.
Crossref
Crossref
Kyle Quirk & Maximillian Stevenson. (2022) Buprenorphine Microdosing for the Pain and Palliative Care Clinician. Journal of Palliative Medicine 25:1, pages 145-154.
Crossref
Crossref
K. K. Adams, M. Machnicz & D. M. Sobieraj. (2021) Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: a systematic review. Addiction Science & Clinical Practice 16:1.
Crossref
Crossref
James S. H. Wong, Mohammadali Nikoo, Jean N. Westenberg, Janet G. Suen, Jennifer Y. C. Wong, Reinhard M. Krausz, Christian G. Schütz, Marc Vogel, Jesse A. Sidhu, Jessica Moe, Shane Arishenkoff, Donald Griesdale, Nickie Mathew & Pouya Azar. (2021) Comparing rapid micro-induction and standard induction of buprenorphine/naloxone for treatment of opioid use disorder: protocol for an open-label, parallel-group, superiority, randomized controlled trial. Addiction Science & Clinical Practice 16:1.
Crossref
Crossref
Martin Busch, Charlotte Klein, Alfred Uhl, Hans Haltmayer, Maurice Cabanis, Jean Nicolas Westenberg, Marc Vogel & R. Michael Krausz. (2021) Retention in the Austrian opioid agonist treatment system: a national prospective cohort study. Harm Reduction Journal 18:1.
Crossref
Crossref
Alexander Dufort & Zainab Samaan. (2021) Problematic Opioid Use Among Older Adults: Epidemiology, Adverse Outcomes and Treatment Considerations. Drugs & Aging 38:12, pages 1043-1053.
Crossref
Crossref
Amy A. Case, Justin Kullgren, Sidra Anwar, Sandra Pedraza & Mellar P. Davis. (2021) Treating Chronic Pain with Buprenorphine—The Practical Guide. Current Treatment Options in Oncology 22:12.
Crossref
Crossref
Jessica L. Taylor, Samantha Johnson, Ricardo Cruz, Jessica R. Gray, Davida Schiff & Sarah M. Bagley. (2021) Integrating Harm Reduction into Outpatient Opioid Use Disorder Treatment Settings. Journal of General Internal Medicine 36:12, pages 3810-3819.
Crossref
Crossref
Michael Soyka. (2021) Transition From Full Mu Opioid Agonists to Buprenorphine in Opioid Dependent Patients—A Critical Review. Frontiers in Pharmacology 12.
Crossref
Crossref
Shannon Menard & Archana Jhawar. (2021) Microdose induction of buprenorphine-naloxone in a patient using high dose methadone: A case report. Mental Health Clinician 11:6, pages 369-372.
Crossref
Crossref
Erin M. Cleary, Marcela C. Smid, Jasmin E. Charles, Kaitlyn M. Jones, Maged M. Costantine, George Saade & Kara M. Rood. (2021) Buprenorphine X-waiver exemption – beyond the basics for the obstetrical provider. American Journal of Obstetrics & Gynecology MFM 3:6, pages 100451.
Crossref
Crossref
Victoria D. Powell, Jack M. Rosenberg, Avani Yaganti, Claire Garpestad, Pooja Lagisetty, Carol Shannon & Maria J. Silveira. (2021) Evaluation of Buprenorphine Rotation in Patients Receiving Long-term Opioids for Chronic Pain. JAMA Network Open 4:9, pages e2124152.
Crossref
Crossref
Madison IrwinKetti S. PetersenMichael A. Smith. (2021) Rapid Buprenorphine Induction for Cancer Pain in Pregnancy. Journal of Palliative Medicine 24:8, pages 1257-1262.
Crossref
Crossref
Parisa Mortaji, Dale Terasaki & Jaime Moo-Young. (2021) Advanced Inpatient Management of Opioid Use Disorder in a Patient Requiring Serial Surgeries. Journal of General Internal Medicine 36:8, pages 2448-2451.
Crossref
Crossref
David A Fishbain. (2021) Opioid Tapering/Detoxification Protocols, A Compendium: Narrative Review. Pain Medicine 22:7, pages 1676-1697.
Crossref
Crossref
Saeed Ahmed, Siddhi Bhivandkar, Brady B. Lonergan & Joji Suzuki. (2020) Microinduction of Buprenorphine/Naloxone: A Review of the Literature. The American Journal on Addictions 30:4, pages 305-315.
Crossref
Crossref
Anthony J. Accurso. (2021) Blister-Packing of 2 mg Buprenorphine Monoproduct as a Patient-Centered Method of Microdosing for Buprenorphine Induction. Clinical Drug Investigation 41:7, pages 663-664.
Crossref
Crossref
Megan Buresh, Robert Stern & Darius Rastegar. (2021) Treatment of opioid use disorder in primary care. BMJ, pages n784.
Crossref
Crossref
Bridget M. Galati, Ebony B. Carter, Marta Perez, Sharman Russell, Sarah Nazeer, Nandini Raghuraman & Jeannie C. Kelly. (2021) Buprenorphine Patch as a Bridge to Sublingual Treatment of Opioid Use Disorder in Pregnancy. Obstetrics & Gynecology 137:4, pages 713-716.
Crossref
Crossref
Joseph Tay Wee Teck, Alexander Baldacchino, Lauren Gibson & Con Lafferty. (2021) Using Microdosing to Induct Patients Into a Long-Acting Injectable Buprenorphine Depot Medication in Low Threshold Community Settings: A Case Study. Frontiers in Pharmacology 12.
Crossref
Crossref
Kelly Crane, Jessica Snead, Robert Stanley, Jonathan Avery, Sumantra Monty Ghosh & Gregory Mints. (2021) Intravenous Buprenorphine Micro-dosing Induction in a Patient on Methadone Treatment: A Case Report. Journal of the Academy of Consultation-Liaison Psychiatry 62:2, pages 243-247.
Crossref
Crossref
Jessica Moe, Fiona O'Sullivan, Corinne M. Hohl, Mary M. Doyle-Waters, Claire Ronsley, Raymond Cho, Qixin Liu & Pouya Azar. (2021) Short communication: Systematic review on effectiveness of micro-induction approaches to buprenorphine initiation. Addictive Behaviors 114, pages 106740.
Crossref
Crossref
Denis Antoine, Andrew S. Huhn, Eric C. Strain, Gavin Turner, Jasmyne Jardot, Alexis S. Hammond & Kelly E. Dunn. (2020) Method for Successfully Inducting Individuals Who Use Illicit Fentanyl Onto Buprenorphine/Naloxone. The American Journal on Addictions 30:1, pages 83-87.
Crossref
Crossref
Amer Raheemullah & Anna Lembke. (2021) Buprenorphine Induction Without Opioid Withdrawal: A Case Series of 15 Opioid-Dependent Inpatients Induced on Buprenorphine Using Microdoses of Transdermal Buprenorphine. American Journal of Therapeutics 28:4, pages e504-e508.
Crossref
Crossref
Zoe M. Weinstein & Honora Englander. 2021. Treating Opioid Use Disorder in General Medical Settings. Treating Opioid Use Disorder in General Medical Settings
43
56
.
Bradley M. Buchheit, Timothy Joslin, Helen N. Turner & Trisha E. Wong. (2020) Ambulatory microdose induction of buprenorphine‐naloxone in two adolescent patients with sickle cell disease. Pediatric Blood & Cancer 68:1.
Crossref
Crossref
Jennifer Rozylo, Keren Mitchell, Mohammadali Nikoo, S. Elise Durante, Skye P. Barbic, Daniel Lin, Steve Mathias & Pouya Azar. (2020) Case report: Successful induction of buprenorphine/naloxone using a microdosing schedule and assertive outreach. Addiction Science & Clinical Practice 15:1.
Crossref
Crossref
Jessica Moe, Mary M. Doyle-Waters, Fiona O'Sullivan, Corinne M. Hohl & Pouya Azar. (2020) Effectiveness of micro-induction approaches to buprenorphine initiation: A systematic review protocol. Addictive Behaviors 111, pages 106551.
Crossref
Crossref
Pouya Azar, James S.H. Wong, Sara Jassemi, Eva Moore, Dzung X. Vo, Mohammadali Nikoo & Samantha Young. (2020) A Case Report: Rapid Micro‐Induction of Buprenorphine/Naloxone to Administer Buprenorphine Extended‐Release in an Adolescent With Severe Opioid Use Disorder. The American Journal on Addictions 29:6, pages 531-535.
Crossref
Crossref
Basia Hamata, Donald Griesdale, Jessica Hann & Pouya Rezazadeh-Azar. (2020) Rapid Micro-induction of Buprenorphine/Naloxone for Opioid Use Disorder in a Critically ill Intubated Patient: A Case Report. Journal of Addiction Medicine 14:6, pages 514-517.
Crossref
Crossref
Kathryn R Kinasz, Ellen D Herbst & Raj K Kalapatapu. (2020) Case Report: Buprenorphine Induction Using Transdermal Buprenorphine in a Veteran With Opioid Use Disorder and Psychosis, Managing Precipitated Withdrawal. Military Medicine 185:9-10, pages e1872-e1875.
Crossref
Crossref
Jonathan Callan, Jarratt Pytell, Julia Ross & Darius A. Rastegar. (2020) Transition From Methadone to Buprenorphine Using a Short-acting Agonist Bridge in the Inpatient Setting: A Case Study. Journal of Addiction Medicine 14:5, pages e274-e276.
Crossref
Crossref
Joao P. De Aquino, Christopher Fairgrieve, Sukhpreet Klaire & Gabriela Garcia-Vassallo. (2020) Rapid Transition From Methadone to Buprenorphine Utilizing a Micro-dosing Protocol in the Outpatient Veteran Affairs Setting. Journal of Addiction Medicine 14:5, pages e271-e273.
Crossref
Crossref
Valerie Giang, Madison Thulien, Ryan McNeil, Kali Sedgemore, Haleigh Anderson & Danya Fast. (2020) Opioid agonist therapy trajectories among street entrenched youth in the context of a public health crisis. SSM - Population Health 11, pages 100609.
Crossref
Crossref
William C. BeckerJoseph W. Frank & Ellen L. Edens. (2020) Switching From High-Dose, Long-Term Opioids to Buprenorphine: A Case Series. Annals of Internal Medicine 173:1, pages 70-71.
Crossref
Crossref
Rupinder Brar, Nadia Fairbairn, Christy Sutherland & Seonaid Nolan. (2020) Use of a novel prescribing approach for the treatment of opioid use disorder: Buprenorphine/naloxone micro‐dosing – a case series. Drug and Alcohol Review 39:5, pages 588-594.
Crossref
Crossref
Naveen K. Dhagudu, Atul Ambekar, Alok Agrawal, Ravindra Rao, Ashwani K. Mishra, Raka Jain & Shalini Singh. (2020) Is there enough naloxone to deter the diversion? Effect of concurrent administration of intravenous naloxone on opioid agonist effects of intravenous buprenorphine: A randomised, double‐blind, within‐subject, crossover study among opioid‐dependent subjects. Drug and Alcohol Review 39:5, pages 595-603.
Crossref
Crossref
Dale Terasaki & Kaylin Klie. (2020) Tramadol Withdrawal in the Setting of Buprenorphine Induction: A Case Report. Journal of Addiction Medicine 14:3, pages 264-266.
Crossref
Crossref
Mackenzie Duncan Gregory Caulfield, Rupinder Brar, Christy Sutherland & Seonaid Nolan. (2020) Transitioning a patient from injectable opioid agonist therapy to sublingual buprenorphine/naloxone for the treatment of opioid use disorder using a microdosing approach. BMJ Case Reports 13:3, pages e233715.
Crossref
Crossref
Reuben J. Strayer, Kathryn Hawk, Bryan D. Hayes, Andrew A. Herring, Eric Ketcham, Alexis M. LaPietra, Joshua J. Lynch, Sergey Motov, Zachary Repanshek, Scott G. Weiner & Lewis S. Nelson. (2020) Management of Opioid Use Disorder in the Emergency Department: A White Paper Prepared for the American Academy of Emergency Medicine. The Journal of Emergency Medicine 58:3, pages 522-546.
Crossref
Crossref
Danny S. Lee, Jessica E. Hann, Sukhpreet S. Klaire, Mohammadali Nikoo, Michael D. Negraeff & Pouya Rezazadeh-Azar. (2020) Rapid Induction of Buprenorphine/Naloxone for Chronic Pain Using a Microdosing Regimen: A Case Report. A&A Practice 14:2, pages 44-47.
Crossref
Crossref
Isaiah T. Crum, VaKara M. Meyer Karre & Alëna A. Balasanova. (2020) Transitioning From Intrathecal Hydromorphone to Sublingual Buprenorphine–Naloxone Through Microdosing: A Case Report. A&A Practice 14:11, pages e01316.
Crossref
Crossref
Victor M. Tang, Jessica Lam‐Shang‐Leen, Thomas D. Brothers, Keith Hansen, Alexander Caudarella, Wiplove Lamba & Tim Guimond. (2019) Case Series: Limited Opioid Withdrawal With Use of Transdermal Buprenorphine to Bridge to Sublingual Buprenorphine in Hospitalized Patients. The American Journal on Addictions 29:1, pages 73-76.
Crossref
Crossref
Sumantra Monty Ghosh, Sukhpreet Klaire, Robert Tanguay, Mandy Manek & Pouya Azar. (2019) A Review of Novel Methods To Support The Transition From Methadone and Other Full Agonist Opioids To Buprenorphine/Naloxone Sublingual In Both Community and Acute Care Settings. The Canadian Journal of Addiction 10:4, pages 41-50.
Crossref
Crossref
Melissa Weimer, Kenneth Morford & Joseph Donroe. (2019) Treatment of Opioid Use Disorder in the Acute Hospital Setting: a Critical Review of the Literature (2014–2019). Current Addiction Reports 6:4, pages 339-354.
Crossref
Crossref
Lindsay Fox & Lewis S. Nelson. (2019) Emergency Department Initiation of Buprenorphine for Opioid Use Disorder: Current Status, and Future Potential. CNS Drugs 33:12, pages 1147-1154.
Crossref
Crossref
Dale Terasaki, Christopher Smith & Susan L. Calcaterra. (2019) Transitioning Hospitalized Patients with Opioid Use Disorder from Methadone to Buprenorphine without a Period of Opioid Abstinence Using a Microdosing Protocol. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 39:10, pages 1023-1029.
Crossref
Crossref
Sukhpreet Klaire, Rebecca Zivanovic, Skye Pamela Barbic, Raman Sandhu, Nickie Mathew & Pouya Azar. (2019) Rapid Micro‐Induction of Buprenorphine/Naloxone for Opioid Use Disorder in an Inpatient Setting: A Case Series. The American Journal on Addictions 28:4, pages 262-265.
Crossref
Crossref
Marc Vogel & Marc Walter. (2019) Opioid- und Mehrfachabhängigkeit. PSYCH up2date 13:04, pages 287-303.
Crossref
Crossref
S. Monty Ghosh, Lydia Vezina, Alvis Yu, Abhishek Jariwala, Ronald Lim & Robert Tanguay. (2019) Exploring Slow Release Oral Morphine (SROM) As a Transition Bridge for Medium to High Doses of Methadone Conversion to Buprenorphine/Naloxone Sublingual: A Calgary Concept and Approach. Canadian Journal of Addiction 10:2, pages 18-24.
Crossref
Crossref
Sarah G. Mars, Daniel Rosenblum & Daniel Ciccarone. (2019) Fentanyl: the many challenges ahead. Addiction 114:5, pages 785-786.
Crossref
Crossref
Carlos Nordt, Marc Vogel, Michelle Dey, Andreas Moldovanyi, Thilo Beck, Toni Berthel, Marc Walter, Erich Seifritz, Kenneth M. Dürsteler & Marcus Herdener. (2019) One size does not fit all-evolution of opioid agonist treatments in a naturalistic setting over 23 years. Addiction 114:1, pages 103-111.
Crossref
Crossref
David H. Cisewski, Cynthia Santos, Alex Koyfman & Brit Long. (2019) Approach to buprenorphine use for opioid withdrawal treatment in the emergency setting. The American Journal of Emergency Medicine 37:1, pages 143-150.
Crossref
Crossref
Keith G. Heinzerling. 2019. The Assessment and Treatment of Addiction. The Assessment and Treatment of Addiction
137
156
.
Thomas Kyle Harrison, Howard Kornfeld, Anuj Kailash Aggarwal & Anna Lembke. (2018) Perioperative Considerations for the Patient with Opioid Use Disorder on Buprenorphine, Methadone, or Naltrexone Maintenance Therapy. Anesthesiology Clinics 36:3, pages 345-359.
Crossref
Crossref
Nika Sulakvelidze, Clare Ronan, Alyssa F. Peterkin & Zoe M. Weinstein. (2022) Efficacy of Low-Dose Versus Traditional Buprenorphine Induction in the Hospital: A Quantitative and Qualitative Study. SSRN Electronic Journal.
Crossref
Crossref